» Authors » Gui-Fu Wu

Gui-Fu Wu

Explore the profile of Gui-Fu Wu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 190
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu X, Wang Z, Zhang Q, Wang J, Jia X, Hao L, et al.
J Biomech . 2024 Dec; 179():112487. PMID: 39709855
Enhanced external counterpulsation (EECP) is widely utilized in rehabilitating patients after percutaneous coronary intervention (PCI) and has demonstrated efficacy in promoting cardiovascular function recovery. Although the precise mechanisms of the...
2.
Zhang X, Zhang Q, Wu G, Hu H, Lin L, Tian S, et al.
Comput Methods Programs Biomed . 2024 Jul; 255:108333. PMID: 39047576
Background And Objective: Diabetic foot (DF) complications often lead to severe vascular issues. This study investigated the effectiveness of enhanced external counterpulsation (EECP) and its derived innovative compression strategies in...
3.
Liao S, Li Y, Cao S, Xue C, Tian S, Wu G, et al.
Comput Methods Programs Biomed . 2024 Apr; 250:108191. PMID: 38677079
Background And Objective: Enhanced external counterpulsation (EECP) is a mechanically assisted circulation technique widely used in the rehabilitation and management of ischemic cardiovascular diseases. It contributes to cardiovascular functions by...
4.
Zhang Q, Zhang Y, Hao L, Xu X, Wu G, Lin L, et al.
J Biomech . 2024 Mar; 166:112057. PMID: 38520934
Enhanced external counterpulsation (EECP) is a treatment and rehabilitation approach for ischemic diseases, including coronary artery disease. Its therapeutic benefits are primarily attributed to the improved blood circulation achieved through...
5.
Chen Y, Xu X, Lin L, Tian S, Wu G
Int J Med Sci . 2023 Jun; 20(7):836-848. PMID: 37324184
Atherosclerosis is a chronic, inflammatory disease characterized by a lipid-driven infiltration of inflammatory cells in large and medium arteries and is considered to be a major underlying cause of cardiovascular...
6.
Li X, Li H, Zhang Y, Gao S, Dong C, Wu G
AAPS PharmSciTech . 2017 Apr; 18(7):2774-2782. PMID: 28361455
Methotrexate (MTX; an anti-folate) and etanercept (ET; a TNF-α inhibitor) are used against arthritis; however, limitations like short biological half-life, low cutaneous absorption, and acidic instability limit their clinical relevance....
7.
Wu X, Fan W, Fang R, Wu G
J Cell Biochem . 2014 Jun; 115(11):1928-36. PMID: 24905663
Increasing evidences have illuminated the fundamental role of inflammation in mediating all stages of atherosclerosis. miR-155, a typical multi-functional miRNA, has recently emerged as a novel component of inflammatory signal...
8.
Xiong Y, Ren Y, Xu J, Yang D, He X, Luo J, et al.
Int J Cardiol . 2014 Jan; 171(2):161-8. PMID: 24380498
Objectives: Enhanced external counterpulsation (EECP) could improve endothelium-dependent vasodilatation of carotid artery and restore imbalance of nitric oxide and endothein-1 in patients with coronary artery disease. Our study was designed...
9.
Liu R, Liang Z, Liao X, Hu C, Jiang L, Dai G, et al.
Am J Emerg Med . 2013 Sep; 31(12):1638-45. PMID: 24060327
Background: To investigate the therapeutic value of enhanced external counterpulsation (EECP) on recovery of cerebral blood flow following cardiac arrest (CA) and successful resumption of spontaneous circulation (ROSC) by cardiopulmonary...
10.
Hu C, Ke X, Chen K, Yang D, Du Z, Wu G
Chin Med J (Engl) . 2013 Apr; 126(8):1480-5. PMID: 23595381
Background: Cell transplantation has great potential for promoting endothelial repair and reducing the complications of percutaneous coronary intervention (PCI). The aim of this study was to investigate the effect of...